Are you Dr. Denardo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 18 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4501 X St
Suite 3016
Sacramento, CA 95817Phone+1 916-734-3787Fax+1 916-451-2857
Summary
- Dr. Sally Denardo, MD is a board certified nuclear medicine physician in Sacramento, California.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1969 - 1971- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1965 - 1969
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1965
Certifications & Licensure
- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
Publications & Presentations
PubMed
- 3 citationsQuo vadis radioimmune imagingGerald L. DeNardo, Sally J. DeNardo
Journal of Nuclear Medicine. 1990-08-01 - 10 citationsPrediction of myelotoxicity using semi-quantitative marrow image scoresSang Moo Lim, Gerald L. DeNardo, Diane A. DeNardo, Robert T. O'Donnell, Aina Yuan
Journal of Nuclear Medicine. 1997-11-01 - 10 citationsA preliminary cell kinetics model of thrombocytopenia after radioimmunotherapySui Shen, Gerald L. DeNardo, Troyce D. Jones, Richard B. Wilder, Robert T. O'Donnell
Journal of Nuclear Medicine. 1998-07-01
Grant Support
- Lymphoma-Specific Ligands;Pharmacokinetics, Radioimaging And TherapeuticsNational Cancer Institute2007–2009
- Lymphoma-Specific Ligands;Pharmacokinetics, Radioimaging And TherpeuticsNational Cancer Institute2005–2006
- Novel Approaches To Pretargeted RadioimmunotherapyNational Cancer Institute2004–2006
- Core--Radiopharmaceutical DevelopmentNational Cancer Institute1999–2006
- Development Of Immunoconjugate Therapy For Breast CancerNational Cancer Institute1994–1999
- Clinical Trials Of Biological Response ModifiersNational Cancer Institute1993–1994
- Core--ImmunopathologyNational Cancer Institute1991–1993
- Core--Cellular And Molecular ImmunobiologyNational Cancer Institute1991–1993
- Core--Antibody PharmacyNational Cancer Institute1991–1993
